Clinical Features	Time to Death		AGE		GENDER		KARNOFSKY.PERFORMANCE.SCORE		PATHOLOGY.T		PATHOLOGY.N		PATHOLOGICSPREAD(M)		NEOADJUVANT.THERAPY	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q
CT47B1	3 (1%)	290	NA	NA	0.68479	1	1	1	NA	NA	1	1	1	1	1	1	1	1
PCDHA10	5 (2%)	288	0.84446	1	0.43242	1	1	1	NA	NA	0.26248	1	1	1	1	1	1	1
WDR46	3 (1%)	290	0.9398	1	0.58392	1	1	1	NA	NA	0.24366	1	1	1	1	1	1	1
PCDHGA1	4 (1%)	289	0.68117	1	0.73732	1	1	1	NA	NA	0.60567	1	0.075342	1	0.43703	1	1	1
USP48	3 (1%)	290	0.67411	1	0.60747	1	1	1	NA	NA	1	1	0.14549	1	0.34955	1	1	1
ABCC10	3 (1%)	290	0.21596	1	0.59565	1	1	1	NA	NA	0.091728	1	1	1	0.047561	1	1	1
PCDHGA8	4 (1%)	289	0.25091	1	0.20698	1	1	1	NA	NA	1	1	1	1	1	1	1	1
KHK	3 (1%)	290	0.02533	1	0.18047	1	1	1	NA	NA	0.71834	1	1	1	0.34955	1	1	1
PCDHB10	3 (1%)	290	0.38946	1	0.25372	1	0.27848	1	NA	NA	1	1	1	1	0.34955	1	1	1
PCDHA6	4 (1%)	289	0.034931	1	0.076148	1	0.61241	1	NA	NA	0.061282	1	0.21076	1	0.087133	1	1	1
PCDHB7	4 (1%)	289	0.23979	1	0.54281	1	1	1	NA	NA	1	1	1	1	1	1	1	1